Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P36
Within normal range
vs 5Y Ago
-2.1x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -13.71% |
| Q2 2025 | -11.68% |
| Q1 2025 | -10.41% |
| Q4 2024 | -3.64% |
| Q3 2024 | -8.11% |
| Q2 2024 | -6.83% |
| Q1 2024 | -5.79% |
| Q4 2023 | -7.00% |
| Q3 2023 | -5.70% |
| Q2 2023 | -7.40% |
| Q1 2023 | -3.99% |
| Q4 2022 | -4.76% |
| Q3 2022 | -4.91% |
| Q2 2022 | -3.63% |
| Q1 2022 | -2.22% |
| Q4 2021 | -2.27% |
| Q3 2021 | -5.74% |
| Q2 2021 | -21.46% |
| Q1 2021 | 414.21% |
| Q4 2020 | -69.79% |
| Q3 2020 | 6.56% |
| Q2 2020 | -23.62% |
| Q1 2020 | -17.18% |
| Q4 2019 | -12.41% |
| Q3 2019 | -14.47% |
| Q2 2019 | -35.23% |
| Q1 2019 | 121.42% |
| Q4 2018 | -34.23% |
| Q3 2018 | -53.80% |
| Q2 2018 | -81.45% |
| Q1 2018 | 809.59% |
| Q4 2017 | 5.59% |
| Q3 2017 | -44.94% |
| Q2 2017 | -7.05% |
| Q1 2017 | -50.67% |
| Q4 2016 | -54.32% |
| Q3 2016 | 92.21% |
| Q2 2016 | -41.18% |
| Q1 2016 | -11.09% |
| Q4 2015 | -63.71% |